Bioequivalence study of Glimepride Tablet [Study As­sess­ment]

posted by Ibrahim Komeil – Egypt, 2021-02-15 11:07 (722 d 05:43 ago) – Posting: # 22208
Views: 1,226

Dear All
I hope you are all fine
Recently i had got results of bioequivalence study for Glimepride Tablet 1 mg applying two way crossover design with 26 volunteers
The results are shown below:
Cmax: PI = 0.75, 90% CI [0.672 - 0.845]
AUCt:  PI = 0.82, 90% CI [0.754 - 1.042]

I am confusing to be sure that the test product is bad , so i am asking your help to know the real cause of these results.

Thank you in advance


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
23 visitors (0 registered, 23 guests [including 8 identified bots]).
Forum time: 16:50 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5